Mason-Pfizer monkey virus

From WikiProjectMed
Jump to navigation Jump to search
Mason-Pfizer monkey virus
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Pararnavirae
Phylum: Artverviricota
Class: Revtraviricetes
Order: Ortervirales
Family: Retroviridae
Genus: Betaretrovirus
Species:
Mason-Pfizer monkey virus
Member viruses[1]
Synonyms[2]
  • Simian retrovirus (SRV)
  • Simian type D virus 1

Mason-Pfizer monkey virus (M-PMV), formerly Simian retrovirus (SRV), is a species of retroviruses that usually infect and cause a fatal immune deficiency in Asian macaques.[3] The ssRNA virus appears sporadically in mammary carcinoma of captive macaques at breeding facilities which expected as the natural host, but the prevalence of this virus in feral macaques remains unknown.[4] M-PMV was transmitted naturally by virus-containing body fluids (saliva, urine, blood, etc.), via biting, scratching, grooming, and fighting. Cross contaminated instruments or equipment (fomite) can also spread this virus among animals.

Some clinical and pathological symptoms of M-PMV-infected newborn rhesus macaques are diarrhea, weight loss, splenomegaly, lymphadenopathy, anemia, neutropenia, and neoplastic diseases (retroperitoneal fibromatosis or rare B-cell lymphomas). Infected new-born Rhesus monkeys may develop immunodeficiency disease accompanied by opportunistic infections.[5] To prevent the infection of this virus, two vaccines have been developed: a formalin-inactivated vaccine SRV-1 and a recombinant vaccine expressing M-PMV envelope glycoprotein gp70 and gp22.[3]

M-PMV-based vector is a candidate for delivering therapeutic genes in human gene transfer. Based on the M-PMV 1) promoter region remain transcriptionally active in human cells and 2) the constitutive transport element (CTE) expression in the target cells aids the facilitation of the nuclear export for the gene therapy.[5]

History

Mason-Pfizer monkey virus (M-PMV) derived from breast tumor tissue of an 8 years-old female rhesus macaque (Macaca mulatta) in 1970 by Dr. Harish C. Chopra and Marcus M. Mason.[6] Initial discovery suspected the virus particles to be an oncogenic virus due to its resemblance to known oncogenic RNA virus (MMTV). Shortly after its discovery, M-PMV was considered to induce simian AIDS (SAIDs). However, current studies have shown that M-PMV is unrelated to simian immunodeficiency virus (SIV), which is currently recognized as the simian counterpart of the human immunodeficiency virus.[7]

M-PMV now belongs to SRV-3. SRV-1 serotype was identified in the early 1980s in rhesus macaque, M. cyclopis, and M. fascicularis at National Primate Research Center (NPRC), California and New England. The SRV serotype-2 was found in endemic infections of pig-tailed monkey (M. nemestrina), cynomolgus macaques, a Japanese macaque (M. fuscata), at Washington NPRC, and in rhesus and Celebes black macaques (M. nigra) at Oregon NPRC.[8] SRV-3 is present at Wisconsin Primate Center, while SRV-4 and SRV-5 have been identified at University of California and Beijing Primate Center. In 2010, a Japanese research group reported two SRV isolates from seropositive cynomolgus macaques and tentatively designated them as SRV/D-Tsukuba (SRV/D-T).[3]

In 2011, players of Foldit helped to decipher the crystal structure of the M-PMV retroviral protease. While the puzzle was available to play for three weeks, players produced an accurate 3D model of the enzyme in just ten days, which was then used to solve the structure with molecular replacement. The problem of how to configure the structure of the enzyme had stumped scientists for 15 years.[9][10] Until 2015, seven serotype of M-PMV have been identified.[citation needed]

Classification

Mason-Pfizer monkey viruses are group VI retrovirus belongs to betaretrovirus genus of orthoretroviridae subfamily. M-PMV was classified based on viral serotype as simian retrovirus type 3 (SRV-3).[11]

Distinguished from other orthoretroviruses for its accumulation of A-type (immature particles) intracellular particles morphology in the cytoplasm and spherical nucleocapsid.[12] Once assemble is complete in the cytosol, particles are then transported to the plasma membrane to complete the maturation process by producing exogenous mature particles (D-type morphology). D-type particles contain fewer dense surface spikes and contain icosahedral capsids.[13]

Morphology and genetic structure

M-PMV is an enveloped RNA retrovirus with an icosahedral capsid (20 triangular faces and 12 vertices). The nucleic acid is encapsulated inside the spherical core. The enveloped virus is made up of lipid bilayer derived from host cell and virus-specific proteins. The matrix protein binds with nucleocapsid while lining the inner surface of the envelope to facilitate the viral genome assembly and budding process.[7] The retroviral replication process steps include Gag particle formation, transport to the membrane (attachment), entry into the cell, uncoating of the viral capsid, release the genome, synthesis of new viral proteins and nucleic acids, assemble of progeny virions, budding, and viral release.[citation needed]

About 60% of the virion dry weight made up of proteins, 35% of lipids, around 3% carbohydrate.[11] The reverse transcriptase made up of 1771 amino acid protein, gp70 surface 586 aa protein, Pr95 911 aa protein, and Pr78 657 aa protein.[14] Based on its structure, the M-PMV is sensitive to formaldehyde, high temperature (heat), and detergents.[11] 

M-PMV contains two types of virus particles.[15] One found in the cytoplasm and the other was found extracellularly. The intracytoplasmic particles (A-type) are small, ring-shaped structures, and 70 mµ in diameter. The virions commonly found in a cluster in the cytoplasm and enveloped of the plasma membrane at the cell surface. The immature particles bud intracellular and are not considered to be infectious. Upon completing budding, immature particles undergo the maturation process (D-type) to acquire infectivity. The extracellular mature particles are about 125 nm in diameter, while the nucleoid and core-shell are central cylindrical structures separated by a space of about 8-10 nm.[16]

Genome structure

Mason-Pfizer monkey virus packaging signal
Predicted secondary structure and sequence conservation of MPMV_package
Identifiers
SymbolMPMV_package
RfamRF00459
Other data
RNA typeCis-reg
Domain(s)Eukaryota; Viruses
SOSO:0000233
PDB structuresPDBe

M-PMV genome consists of a dimer of linear, positive-sense, single-stranded RNA.[11] The integrated provirus's fully sequenced genome made up of 8,557 nucleotides in length, two 349 bp LTRs, and transcription of the genome yield an RNA genome of 7,943 nucleotides.[14] Each monomer has a poly(A) tail of 200 nucleotides at the 3' end and has a methylated nucleotide cap structure at the 5' end covalently linked to the viral RNA.  [citation needed] 

The M-PMV genome contains four genes: 5'-gag-pro-pol-env-3'. Gag encodes group-specific antigen (nucleocapsid proteins), Pro for protease, Pol responsible for RNA-dependent DNA polymerase (reverse-transcriptase) region & integrase, and Env encodes the envelope glycoprotein for virion peplomer proteins. Same with all retroviruses, M-PMV can transcribe its RNA genome into double-stranded DNA by using reverse transcriptase enzyme (Mg2+
 dependent for betaretroviruses). Gag protein serves multiple functions during the viral life cycle, including assembly, maturation, and early replication. Distinguished from other retroviruses, M-PMV has three gag-associated polyprotein precursors: Pr78, Pr95 (gag-pro fusion), and Pr180 (gag-pol).[17] The assemble of Pr78 forms an immature capsid that plays an essential role in the early stages of the viral life cycle. The viral protease is responsible for prepping the structural proteins and viral enzymes for the budding process. In all retroviral systems, commonly found a conserved amino acid sequences pol and a gag-pol (Pr180) precursor. The viral envelop glycoprotein precursor is responsible for the secretion and a transmembrane anchor sequence for the virus during the budding process. The immunosuppressive segment in the env sequences of M-PMV found to be around 60% similar (highly conserved) to that of areticuloendotheliosis-associated virus, indicates a similar mechanism in M-PMV-induced disease.[17] Generally, the envelope protein is found to be highly homologous to that of the avian C-type virus.

The 5' UTR of the genome contains a packaging signal that is required for specific RNA encapsidation.[18][19]

Life cycle

The glycoprotein found on the surface of the M-PMV interacts with specific receptors on the host cell surface. Following the attachment, fusion of the viral envelope release of the nucleocapsid into the host's cell membranes. Once inside the cytoplasm, the positive-sense RNA serves as a template for reverse transcriptase to produce cDNA from its viral RNA. The viral cDNA is then integrated into the host cell genome by viral integrase enzyme, where it becomes a permanent genetic element for the life of the cell. The integrated provirus may remain inactivate or be transcribed by host RNA polymerase II into mRNA that is translated to produce regulatory proteins and the viral structural. Once the new viral genomes and proteins have been synthesized, progeny virions are assembled. Capsids are formed as intracytoplasmic particles (A-type). The virus-encoded matrix proteins inserted and restructuring host cell membranes. The virus undergoes maturation as the A-type particles assemble in the cytosol and being transported to plasma membrane. The viral-encoded polyprotein precursors are then processed to become structural proteins and viral enzymes forming D-type particles ready for budding released of the free virion.[20]

Furthermore, the retrovirus Gag polyprotein plays a role in the transportation and assembly of type A particles to the plasma membrane region of host's cell, where assembly and budding occur through the matrix protein to the cell surface.[21] During or shortly thereafter viral budding, viral protease cleaves Gag protein to yield the mature virion-associated proteins includes matrix protein, capsid, nucleocapsid, and other products. The process leads to the condensation of the viral core and is essential for virus infectivity. These mature Gag-cleavage products then repeat the process of infecting new cells and lay roles during the early stages of the viral life cycle.[22]

Ecology

The exogenous and endogenous simian betaretroviruses are naturally indigenous to various species of the genus Macaque. Betaretroviruses infect a variety of mammalian hosts including Old & New World non-human primates (except apes), Squirrel monkey, Colobinae, sheep (Jaagsiekte sheep retrovirus), and goats (Enzootic nasal tumor virus).[15] Betaretrovirus sequences can also be isolated from humans, possum, and mice.  [citation needed]

References

  1. ^ "ICTV 9th Report (2011) Retroviridae". International Committee on Taxonomy of Viruses (ICTV). Archived from the original on December 29, 2018. Retrieved 29 December 2018.
  2. ^ "ICTV Taxonomy history: Mason-Pfizer monkey virus". International Committee on Taxonomy of Viruses (ICTV). Retrieved 29 December 2018.
  3. ^ a b c Montiel NA (October 2010). "An updated review of simian betaretrovirus (SRV) in macaque hosts". Journal of Medical Primatology. 39 (5): 303–14. doi:10.1111/j.1600-0684.2010.00412.x. PMID 20412379. S2CID 27784098.
  4. ^ Iskandriati D, Saepuloh U, Mariya S, Grant RF, Solihin DD, Sajuthi D, Pamungkas J (2010). "Isolation and Characterization of Simian Retrovirus Type D from Macaca fascicularis and M. nemestrina in Indonesia". Microbiology Indonesia. 4 (3): 132–6. doi:10.5454/mi.4.3.6.
  5. ^ a b Pitchai, Fathima Nuzra Nagoor; Ali, Lizna; Pillai, Vineeta Narayana; Chameettachal, Akhil; Ashraf, Syed Salman; Mustafa, Farah; Marquet, Roland; Rizvi, Tahir Aziz (2018-08-07). "Expression, purification, and characterization of biologically active full-length Mason-Pfizer monkey virus (MPMV) Pr78Gag". Scientific Reports. 8 (1): 11793. Bibcode:2018NatSR...811793P. doi:10.1038/s41598-018-30142-0. ISSN 2045-2322. PMC 6081465. PMID 30087395.
  6. ^ Chopra, Harish C.; Mason, Marcus M. (1970-08-01). "A New Virus in a Spontaneous Mammary Tumor of a Rhesus Monkey". Cancer Research. 30 (8): 2081–2086. ISSN 0008-5472. PMID 4195910.
  7. ^ a b Conte, M R; Klikova, M; Hunter, E; Ruml, T; Matthews, S (1997-10-01). "The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly". The EMBO Journal. 16 (19): 5819–5826. doi:10.1093/emboj/16.19.5819. ISSN 0261-4189. PMC 1170213. PMID 9312040.
  8. ^ Philipp-Staheli J, Marquardt T, Thouless ME, Bruce AG, Grant RF, Tsai CC, Rose TM (March 2006). "Genetic variability of the envelope gene of Type D simian retrovirus-2 (SRV-2) subtypes associated with SAIDS-related retroperitoneal fibromatosis in different macaque species". Virology Journal. 3 (11): 11. doi:10.1186/1743-422X-3-11. PMC 1450265. PMID 16515713.
  9. ^ Khatib F, DiMaio F, Cooper S, Kazmierczyk M, Gilski M, Krzywda S, Zabranska H, Pichova I, Thompson J, Popović Z, Jaskolski M, Baker D (September 2011). "Crystal structure of a monomeric retroviral protease solved by protein folding game players". Nature Structural & Molecular Biology. 18 (10): 1175–7. doi:10.1038/nsmb.2119. PMC 3705907. PMID 21926992.
  10. ^ Praetorius D (2011-09-19). "Gamers Decode AIDS Protein That Stumped Researchers For 15 Years In Just 3 Weeks". The Huffington Post. Retrieved 17 November 2016.
  11. ^ a b c d "Retroviridae - Reverse Transcribing DNA and RNA Viruses - Reverse Transcribing DNA and RNA Viruses (2011)". International Committee on Taxonomy of Viruses (ICTV). Archived from the original on December 29, 2018. Retrieved 2020-04-23.
  12. ^ "The Structure of the Retrovirus". web.stanford.edu. Retrieved 2020-05-06.
  13. ^ Sonigo, Pierre; Barker, Christopher; Hunter, Eric; Wain-Hobson, Simon (1986-05-09). "Nucleotide sequence of Mason-Pfizer monkey virus: An immunosuppressive D-type retrovirus". Cell. 45 (3): 375–385. doi:10.1016/0092-8674(86)90323-5. ISSN 0092-8674. PMID 2421920. S2CID 25512466.
  14. ^ a b "Mason-Pfizer monkey virus, complete genome". 2018-08-13. Retrieved 24 April 2020.
  15. ^ a b Bohl, Christopher R.; Brown, Shanna M.; Weldon, Robert A. (2005-11-07). "The pp24 phosphoprotein of Mason-Pfizer monkey virus contributes to viral genome packaging". Retrovirology. 2 (1): 68. doi:10.1186/1742-4690-2-68. ISSN 1742-4690. PMC 1308863. PMID 16274484.
  16. ^ Prokšová, Petra Grznárová; Lipov, Jan; Zelenka, Jaroslav; Hunter, Eric; Langerová, Hana; Rumlová, Michaela; Ruml, Tomáš (2018-10-20). "Mason-Pfizer Monkey Virus Envelope Glycoprotein Cycling and Its Vesicular Co-Transport with Immature Particles". Viruses. 10 (10): 575. doi:10.3390/v10100575. ISSN 1999-4915. PMC 6212865. PMID 30347798.
  17. ^ a b Sonigo, P.; Barker, C.; Hunter, E.; Wain-Hobson, S. (1986-05-09). "Nucleotide sequence of Mason-Pfizer monkey virus: an immunosuppressive D-type retrovirus". Cell. 45 (3): 375–385. doi:10.1016/0092-8674(86)90323-5. ISSN 0092-8674. PMID 2421920. S2CID 25512466.
  18. ^ Mustafa F, Lew KA, Schmidt RD, Browning MT, Rizvi TA (January 2004). "Mutational analysis of the predicted secondary RNA structure of the Mason-Pfizer monkey virus packaging signal". Virus Research. 99 (1): 35–46. doi:10.1016/j.virusres.2003.09.012. PMID 14687944.
  19. ^ Harrison GP, Hunter E, Lever AM (April 1995). "Secondary structure model of the Mason-Pfizer monkey virus 5' leader sequence: identification of a structural motif common to a variety of retroviruses". Journal of Virology. 69 (4): 2175–2186. doi:10.1128/JVI.69.4.2175-2186.1995. PMC 188886. PMID 7884866.
  20. ^ Fine, D.; Schochetman, G. (October 1978). "Type D primate retroviruses: a review". Cancer Research. 38 (10): 3123–3139. ISSN 0008-5472. PMID 80259.
  21. ^ Prchal, Jan; Kroupa, Tomáš; Ruml, Tomáš; Hrabal, Richard (2014-01-21). "Interaction of Mason-Pfizer monkey virus matrix protein with plasma membrane". Frontiers in Microbiology. 4: 423. doi:10.3389/fmicb.2013.00423. ISSN 1664-302X. PMC 3896817. PMID 24478762.
  22. ^ Píchalová, Růžena; Füzik, Tibor; Vokatá, Barbora; Rumlová, Michaela; Llano, Manuel; Dostálková, Alžbĕta; Křížová, Ivana; Ruml, Tomáš; Ulbrich, Pavel (August 2018). "Conserved cysteines in Mason-Pfizer monkey virus capsid protein are essential for infectious mature particle formation". Virology. 521: 108–117. doi:10.1016/j.virol.2018.06.001. ISSN 0042-6822. PMC 6379149. PMID 29906704.

External links

Retrieved from "https://mdwiki.org/wiki/Mason-Pfizer_monkey_virus"